SELLAS Life Sciences (SLS) Amortizatization of Intangibles (2016 - 2017)

SELLAS Life Sciences' (SLS) quarterly Amortizatization of Intangibles came in at $1000.0 in Q4 2017, down 96.3% on a QoQ basis from $27000.0 in Q3 2017.

SELLAS Life Sciences (SLS) Amortizatization of Intangibles (2016 - 2017) Analysis & Trends

SELLAS Life Sciences (SLS) has 2 years of Amortizatization of Intangibles data on file, last reported at $1000.0 in Q4 2017.

  • On a quarterly basis, Amortizatization of Intangibles changed N/A year-over-year to $1000.0 in Q4 2017; TTM through Dec 2017 was $258000.0, a N/A change from a year earlier, with the FY2017 full-year figure at $258000.0, changed N/A from the prior year.
  • Amortizatization of Intangibles for Q4 2017 stood at $1000.0, down from $27000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for SLS reached as high as $650000.0 in Q1 2017 and fell as low as -$420000.0 in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 3.22 Mn
10 SELLAS Life Sciences 1.96 Bn 1.96 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2017 1,000.00
Dec 31, 2017 1,000.00
Sep 30, 2017 27,000.00
Sep 30, 2017 27,000.00
Jun 30, 2017 -420,000.00
Jun 30, 2017 -420,000.00
Mar 31, 2017 650,000.00
Mar 31, 2017 650,000.00
Sep 30, 2016 568,000.00
Sep 30, 2016 568,000.00
Jun 30, 2016 645,000.00
Jun 30, 2016 645,000.00
Mar 31, 2016 67,000.00
Mar 31, 2016 67,000.00